SignalPath builds an integrated clinical trial technology platform used by research sites and sponsors to manage trial execution and site operations. Its product suite has expanded beyond a traditional Clinical Trial Management System (CTMS) to cover coordinator, finance, regulatory, and management workflows from study design to startup to oversight. SignalPath supports over 2,500 trials across 250 sites and has about 3,000 active users on its platform. The company says its large network of interconnected community and academic health systems positions it to reimagine trials and generate new insights. It plans to use new funding to grow its research teams and expand its product suite, and to prepare for the launch of technology-enabled hybrid clinical trials across its research footprint. SignalPath is based in Raleigh, N.C.

Total raised

$18M

Funding rounds

1

Latest round

Series B

Latest activity

Oct 2019